As Expected, Caliper's Q2 Revenues Fall on Drop in Licensing, Contract Revenue | GenomeWeb
This article has been updated to include comments from a conference call and an updated stock quote.
 
NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported a 4 percent decline in second-quarter revenues due to a $3.5 million drop year over year in licensing and contract revenues and contract delays for its Caliper Discovery Alliances and Services business.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.